PhoreMost (@phoremostltd) 's Twitter Profile
PhoreMost

@phoremostltd

PhoreMost is a new-model drug discovery company dedicated to ‘Drugging the Undruggable®’

PhoreAll and PhoreEST are our dedicated inclusion & green initiatives.

ID: 824195150897381377

linkhttp://www.PhoreMost.com calendar_today25-01-2017 10:00:11

537 Tweet

649 Followers

328 Following

PhoreMost (@phoremostltd) 's Twitter Profile Photo

💡 A brilliant idea for helping cancer patients is just an idea until it's put into practice. Here, Cambridge University explores 10 of its spinouts #ChangingTheStoryOfCancer, including PhoreMost, by developing more effective and targeted oncology therapies: tinyurl.com/23etgn8n

💡 A brilliant idea for helping cancer patients is just an idea until it's put into practice.

Here, <a href="/Cambridge_Uni/">Cambridge University</a> explores 10 of its spinouts #ChangingTheStoryOfCancer, including PhoreMost, by developing more effective and targeted oncology therapies: tinyurl.com/23etgn8n
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Our team has arrived in Boston for the TPD and Induced Proximity Summit! 🎤 Visions for the future of TPD and Beyond - 29/10 8:15 🎤 CEO Think Tank - 29/10 9:30 🎤 Discovery of Bifunctional Degraders - 30/10 11:30 🎤 A Systematic Platform to Unlock MGDs - 31/10 13:30

Our team has arrived in Boston for the TPD and Induced Proximity Summit!
🎤 Visions for the future of TPD and Beyond - 29/10 8:15
🎤 CEO Think Tank - 29/10 9:30
🎤 Discovery of Bifunctional Degraders - 30/10 11:30
🎤 A Systematic Platform to Unlock MGDs - 31/10 13:30
PhoreMost (@phoremostltd) 's Twitter Profile Photo

“The next decade promises further innovation in the rational design of molecular glues” In a recent article with The Medicine Maker, Dr Ben Cross explored how innovations in MGDs will overcome limitations of other degraders, improving therapeutic outcomes. 📰tinyurl.com/2bhs7b9y

“The next decade promises further innovation in the rational design of molecular glues”

In a recent article with <a href="/Medicine_maker/">The Medicine Maker</a>, Dr Ben Cross explored how innovations in MGDs will overcome limitations of other degraders, improving therapeutic outcomes.
📰tinyurl.com/2bhs7b9y
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Dr Neil Torbett and Dr Ian Hutchison are at #BIOEurope, meeting with leaders from life sciences to discuss the latest opportunities for collaborative innovation. Interested in learning how we are enabling discovery of degrader therapeutics? Get in touch: [email protected]

Dr Neil Torbett and Dr Ian Hutchison are at #BIOEurope, meeting with leaders from life sciences to discuss the latest opportunities for collaborative innovation.
 
Interested in learning how we are enabling discovery of degrader therapeutics? Get in touch: info@phoremost.com
PhoreMost (@phoremostltd) 's Twitter Profile Photo

We had a great time at the TPD and Induced Proximity Summit, hearing about recent advances in MGDs, degrader therapeutics, and novel TPD mechanisms, as well as sharing updates on our internal pipelines. Missed our presentations? Contact us to learn more: phoremost.com

We had a great time at the TPD and Induced Proximity Summit, hearing about recent advances in MGDs, degrader therapeutics, and novel TPD mechanisms, as well as sharing updates on our internal pipelines.
 
Missed our presentations? Contact us to learn more:
phoremost.com
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Our team is back from a busy week at #BIOEurope! Didn’t manage to schedule a meeting with us in person? Get in touch during the online digital partnering event to learn more about how we’re enabling the discovery of novel degrader therapeutics: [email protected]

Our team is back from a busy week at #BIOEurope!

Didn’t manage to schedule a meeting with us in person? Get in touch during the online digital partnering event to learn more about how we’re enabling the discovery of novel degrader therapeutics: info@phoremost.com
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Founded as a spinout from Cambridge University and supported by its innovation arm Cambridge Enterprise, we are pioneering new technologies to identify druggable targets. Read this case study to learn more about our story: shorturl.at/bg1hY

Founded as a spinout from <a href="/Cambridge_Uni/">Cambridge University</a> and supported by its innovation arm <a href="/UCamEnterprise/">Cambridge Enterprise</a>, we are pioneering new technologies to identify druggable targets.

Read this case study to learn more about our story: shorturl.at/bg1hY
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Our team is in London for the 15th edition of #MedicineAtTheCrick! Hosted by The Francis Crick Institute, today’s symposium explores new frontiers in drug discovery. Get in touch ➡️ phoremost.com/contact

Our team is in London for the 15th edition of #MedicineAtTheCrick!

Hosted by <a href="/TheCrick/">The Francis Crick Institute</a>, today’s symposium explores new frontiers in drug discovery.

Get in touch ➡️ phoremost.com/contact
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Dr Benedict Cross spoke with The Medicine Maker, sharing his insights into innovations in molecular glues and how they can improve therapeutic outcomes by drugging the undruggable. 📰 If you haven’t already, read the full article here: lnkd.in/ecQSjFuE

Dr Benedict Cross spoke with <a href="/medicine_maker/">The Medicine Maker</a>, sharing his insights into innovations in molecular glues and how they can improve therapeutic outcomes by drugging the undruggable.
 
📰 If you haven’t already, read the full article here: lnkd.in/ecQSjFuE
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Have you read our Meet the Team blog series? In the latest edition, we spoke with Dr Jia Lu, Principal Scientist in Target Discovery about his experiences working with mini proteins and the challenges associated with developing molecular glue degraders➡️ tinyurl.com/3fxndnta

Have you read our Meet the Team blog series?
 
In the latest edition, we spoke with Dr Jia Lu, Principal Scientist in Target Discovery about his experiences working with mini proteins and the challenges associated with developing molecular glue degraders➡️ tinyurl.com/3fxndnta
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Next week, we’re off to Barcelona for #DDCEurope! Catch Alberto Moreno De La Gandara, Associate Director for Target Biology, on Day 1 for his talk on #MolecularGlue discovery. For the full agenda, visit ➡️ drugdiscoverychemistry.com/europe/programs

Next week, we’re off to Barcelona for #DDCEurope!
 
Catch Alberto Moreno De La Gandara, Associate Director for Target Biology, on Day 1 for his talk on #MolecularGlue discovery.
 
For the full agenda, visit ➡️ drugdiscoverychemistry.com/europe/programs
PhoreMost (@phoremostltd) 's Twitter Profile Photo

📢A rational approach to molecular glue discovery: GlueSEEKER™ Molecular glues are an exciting class of protein degrader drugs - smaller, simpler than bivalents - but have so far been discovered by serendipity. To address this, we developed GlueSEEKER➡️rb.gy/o2vyjf

📢A rational approach to molecular glue discovery: GlueSEEKER™
Molecular glues are an exciting class of protein degrader drugs - smaller, simpler than bivalents - but have so far been discovered by serendipity. To address this, we developed GlueSEEKER➡️rb.gy/o2vyjf
PhoreMost (@phoremostltd) 's Twitter Profile Photo

#DDCEurope is in full swing! Earlier, Alberto Moreno De La Gandara shared updates on our GlueSEEKER platform in his talk, “Molecular Glue Discovery by High-throughput Neomorphic Remodelling of Effector Proteins”. To learn more, visit ➡️ phoremost.com/science

#DDCEurope is in full swing!
 
Earlier, Alberto Moreno De La Gandara shared updates on our GlueSEEKER platform in his talk, “Molecular Glue Discovery by High-throughput Neomorphic Remodelling of Effector Proteins”.
 
To learn more, visit ➡️ phoremost.com/science
PhoreMost (@phoremostltd) 's Twitter Profile Photo

📢We are recruiting a dedicated and enthusiastic Lab Technician to join our team! Responsibilities include: 🧪 General lab maintenance and housekeeping 🧪 Maintaining lab stocks 🧪 Waste management Find out more and apply here: phoremost.bamboohr.com/careers/53 #Cambridgejobs #Biotech

📢We are recruiting a dedicated and enthusiastic Lab Technician to join our team!

Responsibilities include:
🧪 General lab maintenance and housekeeping
🧪 Maintaining lab stocks
🧪 Waste management

Find out more and apply here: phoremost.bamboohr.com/careers/53

#Cambridgejobs #Biotech
PhoreMost (@phoremostltd) 's Twitter Profile Photo

We had a fantastic evening at Scrip Awards earlier this week! We’re honoured to be shortlisted for the MSD Innovation Award for the 2nd year running, a testament to the potential of our SITESEEKER and GlueSEEKER platforms to unlock new medicines. Congratulations to the winners!

We had a fantastic evening at Scrip Awards earlier this week!

We’re honoured to be shortlisted for the MSD Innovation Award for the 2nd year running, a testament to the potential of our SITESEEKER and GlueSEEKER platforms to unlock new medicines.

Congratulations to the winners!
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Two months after @ELRIG_UK Drug Discovery, it’s great to see the conversations and insights continuing! Check out our poster “Uncovering New Pathways for Targeted Protein Degradation" on News Medical: tinyurl.com/2bmzhs66 #TPD #DegraderTherapeutics

Two months after @ELRIG_UK Drug Discovery, it’s great to see the conversations and insights continuing!

Check out our poster “Uncovering New Pathways for Targeted Protein Degradation" on <a href="/NewsMedical/">News Medical</a>: tinyurl.com/2bmzhs66 

#TPD #DegraderTherapeutics
PhoreMost (@phoremostltd) 's Twitter Profile Photo

🎄 Happy Holidays from PhoreMost 🎄 A big thank you to our team and all our partners for making this year a great one. We’re looking forward to the new year ahead! Merry Christmas and Happy New Year!

🎄 Happy Holidays from PhoreMost 🎄

A big thank you to our team and all our partners for making this year a great one. We’re looking forward to the new year ahead!

Merry Christmas and Happy New Year!
PhoreMost (@phoremostltd) 's Twitter Profile Photo

Exciting announcement! We’ve welcomed Barbara Duncan as Chair and Stephen Dilly as Non-Executive Director to our Board, bringing commercial and leadership expertise to advance our degrader pipeline and the commercialisation of our GlueSEEKER® platform. ➡️shorturl.at/u7Xdr

Exciting announcement! We’ve welcomed Barbara Duncan as Chair and Stephen Dilly as Non-Executive Director to our Board, bringing commercial and leadership expertise to advance our degrader pipeline and the commercialisation of our GlueSEEKER® platform.

➡️shorturl.at/u7Xdr